H. E. DALKILIÇ Et Al. , "Anti-cyclic citrullinated peptide and rheumatoid factor in patients with chronic hepatitis B and hepatitis B carriers," European Journal of Rheumatology , vol.2, no.2, pp.62-65, 2015
DALKILIÇ, H. E. Et Al. 2015. Anti-cyclic citrullinated peptide and rheumatoid factor in patients with chronic hepatitis B and hepatitis B carriers. European Journal of Rheumatology , vol.2, no.2 , 62-65.
DALKILIÇ, H. E., ÖKSÜZ, M. F., tufan, a. n., özbek, a., nizamoğlu, a., DÖLARSLAN, M. E., ... COŞKUN, B. N.(2015). Anti-cyclic citrullinated peptide and rheumatoid factor in patients with chronic hepatitis B and hepatitis B carriers. European Journal of Rheumatology , vol.2, no.2, 62-65.
DALKILIÇ, HÜSEYİN Et Al. "Anti-cyclic citrullinated peptide and rheumatoid factor in patients with chronic hepatitis B and hepatitis B carriers," European Journal of Rheumatology , vol.2, no.2, 62-65, 2015
DALKILIÇ, HÜSEYİN E. Et Al. "Anti-cyclic citrullinated peptide and rheumatoid factor in patients with chronic hepatitis B and hepatitis B carriers." European Journal of Rheumatology , vol.2, no.2, pp.62-65, 2015
DALKILIÇ, H. E. Et Al. (2015) . "Anti-cyclic citrullinated peptide and rheumatoid factor in patients with chronic hepatitis B and hepatitis B carriers." European Journal of Rheumatology , vol.2, no.2, pp.62-65.
@article{article, author={HÜSEYİN EDİZ DALKILIÇ Et Al. }, title={Anti-cyclic citrullinated peptide and rheumatoid factor in patients with chronic hepatitis B and hepatitis B carriers}, journal={European Journal of Rheumatology}, year=2015, pages={62-65} }